Loading…
← CockpitCompetitor Analysis › 002286.SZ Baolingbao Biology Co., Ltd. Class AOpen in the cockpit ↗

Baolingbao Biology Co., Ltd. Class A002286.SZCompetitor analysis, valuation and peers

China · CNY·Consumer Staples›Food: Specialty/Candy
Momentum leader 95
Mkt cap
$515M
US dollars, full cap
Free float
86%
of shares outstanding
$/day
$23.5M
20-day average traded
Fwd P/E
17.1×
forward earnings
ROIC−WACC
+0.8 pp
WACC 7.6%
Hurdle
-1 pp
Req g minus delivered
Next earnings
156 days
23 Apr 2027
Close · CNYCN¥9.10
1D-2.1%
1W+1.4%
1M+13.0%
3M+14.0%
6M-6.4%
YTD+1.8%
1Y-7.0%
ATR %4.9%
52w lowhigh22.2% off high

What Baolingbao Biology does

Employees: 1,505

Baolingbao Biology at a glance

Size Baolingbao Biology (002286.SZ) is a China Consumer Staples company (Food: Specialty/Candy) with a market value of $515M, the 3625th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥9.10 on 18 Nov 2026.

Performance Over six months the shares fell 6.4%, against -10.2% for the median peer and -20.0% for the China market (cap-weighted) — 10th highest of 21 in its peer set.

Growth Revenue grew 6.9% over the last twelve months (peer median +6.7%); the operating margin is 5.5% (peer median 5.9%).

Valuation It trades at 17.1× forward earnings against a peer median of 17.9× (5th cheapest of 14).

Price implies For today's price to make sense, revenue must grow about 5% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is -1 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 0.8 points above its cost of capital (7.6% WACC).

Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).

Relative performance

809010021 May 202621 Aug 202618 Nov 2026002286.SZ 96Peer median 90
Six months, rebased to 100: Baolingbao Biology against the median of its 20 peers (local-currency closes).

Baolingbao Biology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥2.88BCN¥2.74BCN¥2.40BCN¥2.52BCN¥2.71B
Revenue growth—+15%-5%-7%—
Gross profitCN¥487MCN¥344MCN¥267MCN¥182MCN¥276M
EBITDAn/aCN¥303MCN¥277MCN¥189MCN¥266M
Net incomeCN¥131MCN¥151MCN¥111MCN¥54.0MCN¥133M
Free cash flowCN¥156MCN¥158MCN¥89.4MCN¥133M-CN¥218M
Capital expenditureCN¥250MCN¥189MCN¥190MCN¥152MCN¥255M
Total debtCN¥258MCN¥178MCN¥304MCN¥354MCN¥531M

Quarterly statements and history in the cockpit →

Baolingbao Biology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%-20%0%2220VADILALIND4526002991OFRMYASHO6030203009733009080025822003001680220860377780796053000012159279002286.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Baolingbao Biology is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%+30%10×20×30×40×22204526002991300973300908001680220880796053000012156036976038869279002286.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Baolingbao Biology is the large dot.

Capital: growth delivered against growth the price implies

0%+20%0%20%2220VADILALIND4526002991YASHO20030016802208603777605300001215603886002286.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Baolingbao Biology is the large dot.

Baolingbao Biology competitors and peer comparison

How Baolingbao Biology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Baolingbao Biology against its 20 peers (data as of 18 Nov 2026)
Measure002286.SZPeer medianRank in peer set
1-month return+13.0%-2.7%2nd highest of 21
6-month return-6.4%-10.2%10th highest of 21
Distance from 52-week high-22.2%-27.8%9th highest of 21
Revenue growth (TTM)+6.9%+6.7%11th highest of 21
Operating margin5.5%5.9%9th lowest of 21
Forward P/E17.1×17.9×5th cheapest of 14
Growth the price implies (Req g, 7 yrs)4.6%4.0%8th least demanding of 15
Growth delivered (Del g)+6.0%+6.6%8th highest of 15
Hurdle (Req g minus delivered)-1.4 pp-5.3 pp4th most demanding of 15
ROIC minus cost of capital+0.8 pp+0.7 pp11th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Baolingbao Biology 002286.SZChina$515M-6%+7%5%17.1×4.6%+6.0%
Kameda Seika 2220.TJapan$535M+3%+17%6%17.8×0.6%+6.0%
Vadilal Industries VADILALIND.NSIndia$536M+63%+36%16%n/a15.6%+26.5%
Riken Vitamin 4526.TJapan$538M+35%+4%6%12.4×-2.0%+4.4%
Ganyuan Foods 002991.SZChina$551M-16%0%10%17.1×4.8%+12.4%
Once Upon a Farm, PBC OFRMUnited States$481M-29%+38%-7%n/an/an/a
Yasho Industries YASHO.NSIndia$480M+106%+55%15%n/a34.8%+17.7%
Apple Flavor & Fragrance 603020.SSChina$553M-9%+11%4%n/an/an/a
Ligao Foods 300973.SZChina$563M-21%+5%7%16.2×n/an/a
Zhongjing Food 300908.SZChina$564M-37%+6%19%19.2×6.5%+8.3%
Haoxiangni Health Food 002582.SZChina$566M-20%-17%-11%n/an/an/a
Nitto Fuji Flour Milling 2003.TJapan$466M+12%0%6%n/a0.1%+5.2%
Daesang 001680.KSSouth Korea$463M-19%+2%4%8.0×-5.3%+7.2%
Bourbon 2208.TJapan$456M+4%+7%6%20.9×-12.1%+0.3%
Shanghai Laiyifen 603777.SSChina$590M-40%-3%-5%n/a35.2%-0.9%
Shoei Foods 8079.TJapan$445M+6%+8%4%17.9×n/an/a
Jiahe Foods Industry 605300.SSChina$604M-15%-7%1%24.2×18.0%+3.7%
Zhengzhou Qianweiyangchu Food 001215.SZChina$416M-29%+13%5%39.3×12.5%+15.0%
YouYou Foods 603697.SSChina$639M-11%+30%11%19.2×3.1%+7.8%
Ganso 603886.SSChina$412M-1%+5%6%10.1×-14.0%-1.9%
Gift 9279.TJapan$649M+18%+24%11%32.1×n/an/a

Questions

Which companies are Baolingbao Biology's closest peers?
The cockpit's peer set: Kameda Seika (2220.T), Vadilal Industries (VADILALIND.NS), Riken Vitamin (4526.T), Ganyuan Foods (002991.SZ), Once Upon a Farm, PBC (OFRM), Yasho Industries (YASHO.NS), Apple Flavor & Fragrance (603020.SS), Ligao Foods (300973.SZ).
Is Baolingbao Biology expensive compared with its peers?
On forward p/e it trades at 17.1× against a peer median of 17.9×, 5th cheapest of 14 in its peer set. For today's price to make sense, revenue must grow about 5% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is -1 pp: the price already allows for a slowdown.
How has Baolingbao Biology stock performed?
Over six months to 18 Nov 2026 the shares returned -6.4% against -10.2% for the median peer; over one year -7.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.